Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

39 trials with published results (18%)

Research Maturity

125 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

8.2%

18 terminated out of 219 trials

Success Rate

87.4%

+0.8% vs benchmark

Late-Stage Pipeline

7%

16 trials in Phase 3/4

Results Transparency

31%

39 of 125 completed with results

Key Signals

39 with results87% success18 terminated

Data Visualizations

Phase Distribution

171Total
Not Applicable (116)
Early P 1 (4)
P 1 (24)
P 2 (11)
P 3 (10)
P 4 (6)

Trial Status

Completed125
Unknown29
Recruiting23
Terminated18
Active Not Recruiting9
Withdrawn7

Trial Success Rate

87.4%

Benchmark: 86.6%

Based on 125 completed trials

Clinical Trials (219)

Showing 20 of 20 trials
NCT05626816Not ApplicableRecruitingPrimary

Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury

NCT07848308Active Not Recruiting

Clinical Outcomes of Rectopexy for Rectal Prolapse

NCT06152224Phase 4Active Not RecruitingPrimary

Use of the LEVA® Pelvic Health System for Fecal Incontinence

NCT07499258RecruitingPrimary

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

NCT05253196Not ApplicableRecruiting

Enema Device for Children With Spina Bifida

NCT06786091Not ApplicableCompleted

Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment

NCT07034443Not ApplicableRecruitingPrimary

Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation

NCT05776277Phase 3Active Not RecruitingPrimary

Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

NCT07711509Not ApplicableActive Not Recruiting

Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer

NCT04976153Phase 3RecruitingPrimary

Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence

NCT06221046Not ApplicableNot Yet Recruiting

Testing the Safety and Efficacy of a Novel Barrier Cream for the Treatment of Moisture Associated Skin Damage

NCT04806386Not ApplicableCompletedPrimary

The Role of Fiber in the Prevention and Treatment of Fecal Incontinence

NCT07524439Not ApplicableRecruitingPrimary

Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent

NCT06370637Not ApplicableNot Yet Recruiting

Testing a Novel Barrier Cream for Fecal Incontinence in an Ambulatory Population

NCT06785844Early Phase 1RecruitingPrimary

Intra-rectal Botulinum Toxin Injection for Intractable Non-retentive Fecal Incontinence in Children - an Open Label Pilot Study

NCT04506593Recruiting

Indiana University Gastrointestinal Motility Diagnosis Registry

NCT06273046Not ApplicableRecruitingPrimary

Treatment of Fecal Incontinence and Functional Evacuation Disorders Using Non-instrumental Biofeedback

NCT00213317Completed

Effect of Lumbo-sacral Magnetic Stimulation on Colonic Motility

NCT01786304Not ApplicableCompletedPrimary

Effect of Sacral Nerve Stimulation on Enteric Nervous System

NCT07604415Not ApplicableRecruitingPrimary

Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinence

Scroll to load more

Research Network

Activity Timeline